Nanocrystalline Gold to Treat Remyelination Failure in Chronic Optic Neuropathy In Multiple Sclerosis
Conditions: Relapsing Remitting Multiple Sclerosis; Optic Neuropathy; Optic; Neuritis, With Demyelination Interventions: Drug: CNM-Au8; Drug: Placebo Sponsors: Clene Nanomedicine; Clene Australia Pty Ltd Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials